These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 19020660)
1. ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes. Skogsberg J; Dicker A; Rydén M; Aström G; Nilsson R; Bhuiyan H; Vitols S; Mairal A; Langin D; Alberts P; Walum E; Tegnér J; Hamsten A; Arner P; Björkegren J PLoS One; 2008; 3(11):e3771. PubMed ID: 19020660 [TBL] [Abstract][Full Text] [Related]
2. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences. Johnson LA; Altenburg MK; Walzem RL; Scanga LT; Maeda N Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1745-52. PubMed ID: 18617647 [TBL] [Abstract][Full Text] [Related]
3. Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism. Reyes-Soffer G; Sztalryd C; Horenstein RB; Holleran S; Matveyenko A; Thomas T; Nandakumar R; Ngai C; Karmally W; Ginsberg HN; Ramakrishnan R; Pollin TI Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):63-72. PubMed ID: 30580564 [TBL] [Abstract][Full Text] [Related]
4. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans. Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078 [TBL] [Abstract][Full Text] [Related]
5. Glucose enhances catecholamine-stimulated lipolysis via increased glycerol-3-phosphate synthesis in 3T3-L1 adipocytes and rat adipose tissue. Takeuchi N; Higashida K; Li X; Nakai N Mol Biol Rep; 2021 Sep; 48(9):6269-6276. PubMed ID: 34374898 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid. Degrace P; Moindrot B; Mohamed I; Gresti J; Du ZY; Chardigny JM; Sébédio JL; Clouet P J Lipid Res; 2006 Dec; 47(12):2647-55. PubMed ID: 16957181 [TBL] [Abstract][Full Text] [Related]
7. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice. Bell TA; Kelley K; Wilson MD; Sawyer JK; Rudel LL Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1396-402. PubMed ID: 17431188 [TBL] [Abstract][Full Text] [Related]
9. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans. Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893 [TBL] [Abstract][Full Text] [Related]
10. An apolipoprotein B100 mimotope prevents obesity in mice. Kim HJ; Lee HJ; Choi JS; Han J; Kim JY; Na HK; Joung HJ; Kim YS; Binas B Clin Sci (Lond); 2016 Jan; 130(2):105-16. PubMed ID: 26519425 [TBL] [Abstract][Full Text] [Related]
13. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol. Sorci-Thomas M; Wilson MD; Johnson FL; Williams DL; Rudel LL J Biol Chem; 1989 May; 264(15):9039-45. PubMed ID: 2722816 [TBL] [Abstract][Full Text] [Related]
14. The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver. Larsson SL; Skogsberg J; Björkegren J J Biol Chem; 2004 Jan; 279(2):831-6. PubMed ID: 14583618 [TBL] [Abstract][Full Text] [Related]
15. Liraglutide Increases the Catabolism of Apolipoprotein B100-Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression. Vergès B; Duvillard L; Pais de Barros JP; Bouillet B; Baillot-Rudoni S; Rouland A; Petit JM; Degrace P; Demizieux L Diabetes Care; 2021 Apr; 44(4):1027-1037. PubMed ID: 33531418 [TBL] [Abstract][Full Text] [Related]
16. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss. Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431 [TBL] [Abstract][Full Text] [Related]
17. Role of dysfunctional adipocytes in cholesterol-induced nonobese metabolic syndrome. Huang JP; Hsu SC; Meir YJ; Hsieh PS; Chang CC; Chen KH; Chen JK; Hung LM J Mol Endocrinol; 2018 May; 60(4):307-321. PubMed ID: 29581238 [TBL] [Abstract][Full Text] [Related]
18. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins. Huang Y; Liu XQ; Rall SC; Mahley RW J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338 [TBL] [Abstract][Full Text] [Related]
20. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome. Richard C; Couture P; Ooi EM; Tremblay AJ; Desroches S; Charest A; Lichtenstein AH; Lamarche B Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):433-8. PubMed ID: 24265415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]